Use of Primary Prevention Implantable Cardioverter-Defibrillators in a Population-Based Cohort Is Associated With a Significant Survival Benefit | Zendy

Ratika Parkash | Zendy; John L. Sapp | Zendy; Magdy N. Basta | Zendy; Steve Doucette | Zendy; Kara Thompson | Zendy; Martin J. Gardner | Zendy; Chris Gray | Zendy; Brenda Brownell | Zendy; Hena Kidwai | Zendy; Jafna L. Cox | Zendy

Open Access

Use of Primary Prevention Implantable Cardioverter-Defibrillators in a Population-Based Cohort Is Associated With a Significant Survival Benefit

Author(s) -

Ratika Parkash,

John L. Sapp,

Magdy N. Basta,

Steve Doucette,

Kara Thompson,

Martin J. Gardner,

Chris Gray,

Brenda Brownell,

Hena Kidwai,

Jafna L. Cox

Publication year - 2012

Publication title -

circulation arrhythmia and electrophysiology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.684

H-Index - 102

eISSN - 1941-3149

pISSN - 1941-3084

DOI - 10.1161/circep.112.970798

Subject(s) - medicine , implantable cardioverter defibrillator , cohort , hazard ratio , population , sudden cardiac death , retrospective cohort study , cohort study , primary prevention , emergency medicine , confidence interval , disease , environmental health

Underuse of implantable defibrillators has been previously noted in patients at risk for sudden cardiac death, as well as for survivors of sudden cardiac death. We sought to determine the utilization rates in a primary prevention implantable cardioverter-defibrillator (ICD)-eligible population and mortality in this group compared with a group that had undergone implantation of this therapy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research